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6ABBREVIATIONS
ASA Anesthetic risk group (the American Society of Anesthesiologists)
BIS Bispectral index
BPM Beats per minute
BS Burst suppression
BSR Burst suppression ratio
CBF Cerebral blood flow
CH Controlled hyperventilation
CI Confidence interval
CNS Central nervous system
CO Cardiac output
CO2 Carbon dioxide
CV Controlled ventilation
D Delta
DS Delta slow, < 2 Hz
DSM Delta slow, monophasic
DSMS Delta slow, monophasic with spikes
DSP Delta with spikes
ECT Electroconvulsive therapy
ED Effective dose
EEG Electroencephalogram
EPSP Excitatory postsynaptic potential
ET End–tidal
ETCO2 End–tidal carbon dioxide
ETsevo End–tidal sevoflurane concentration
FFT Fast Fourier transformation
FiO2 Fraction of inspired oxygen
GABA Gamma–aminobutyric acid
GM Grand mal, epileptic seizure with tonic–clonic convulsions and characteristic
EEG
HR Heart rate
ISPS Inhibitory postsynaptic potential
kPa kiloPascal
LTL Laparoscopic tubal ligation
LTP Long term potentiation
MAC Minimum alveolar concentration
MAP Mean arterial pressure
MV Minute ventilation
P Power
PaCO2 Arterial carbon dioxide tension
PED Periodic epileptiform discharges
PS Polyspikes
PSP Postsynaptic potential
PSR Polyspikes, rhythmic
PVR Peripheral vascular resistance
S Suppression
SB Spontaneous breathing
SBS Burst suppression with spikes
7SD Standard deviation
SpO2 Peripheral blood oxygen saturation
SSP Suppression with spikes
SV Stroke volume
THIP Tetrahydroxyisoxazolopyridine
VCRII Vital capacity rapid inhalation induction of anesthesia
VF Ventilatory frequency
8INTRODUCTION
Anesthetic adequacy has been assessed from autonomic and movement responses, with
efforts concentrated on maintaining cardiovascular stability along with immobility. However,
movement response in a non–paralyzed subject during anesthesia has been shown to represent
a spinal response (1, 2). Immobility is easily achieved with neuromuscular blocking drugs.
When such drugs are used, neither immobility nor cardiovascular stability − which results
from areflexia in the autonomous nervous system system − can be deemed to represent
depression or the presence of such cortical functions as consciousness and recall. Amount of
sedation, i.e., the sleep–component in balanced anesthesia, has been beyond the scope of
monitoring possibilities. The new empiric EEG index, the bispectral index (BIS), is a
processed, multivariate EEG derivative (3). It has been suggested as a means of monitoring
the anesthetic effect on humans (4) and improving patient outcome after anesthesia (5).
Neuroexcitatory movements have been reported in association with many general
anesthetics. Perioperative convulsions may result in an increase in cerebral metabolism, in
blood flow and in intracranial pressure, which is dangerous to patients at risk for cerebral
ischemia or intracranial hypertension. Use of proconvulsant drugs during anesthesia may
aggravate preexisting epilepsy. Ictal or postictal state (= epileptic seizure or the state
immediately after seizure) may delay emergence from anesthesia, and cause postoperative
confusion and risk of hypoventilation and physical injury to the patient.
Sevoflurane has been suggested as a suitable agent for anesthetic induction for both
adults and children. Sevoflurane inhalation induction has also been reported to maintain
hemodynamic stability (6). The present study was designed to examine the effects of
sevoflurane on EEG and hemodynamics during both induction and maintenance of anesthesia
in elective surgical patients. This was accomplished by BIS monitoring during anesthesia and
surgery, and by time−domain analysis of EEG during induction of anesthesia, with special
reference to EEG and hemodynamic interrelations during sevoflurane inhalation induction.
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ELECTROENCEPHALOGRAPHY
Electrical signals generated in the brain can be recorded from the scalp by means of
electroencephalography (EEG). Electrical currents on the cortex were first described by Caton
in animals (7). Hans Berger began the era of human EEG research in 1929 by his report of
electric potentials recorded from the scalp (8). Four years later, he published the first report on
the effect of an anesthetic agent on the human EEG (9). Eccles proposed that EEG activity
arises from postsynaptic potentials (PSPs) (10). Later, it was shown that both excitatory
(EPSP) and inhibitory postsynaptic potentials (ISPS) contribute to this potential (11). With
ongoing research, evidence accumulated supporting the idea of EEG originating from the sum
of all the excitatory and inhibitory postsynaptic potentials which create extracellular current
flow (12). EEG signals are mainly generated by cortical pyramidal cells, cortical glial and
granular cells may also contribute to some extent. When PSPs appear and disappear, the EEG
scalp voltage changes. Normally, millions of PSPs are firing asynchronously in different
cortical regions, together creating a complex composite signal. Therefore, the normal EEG of
activated cortical areas is desynchronized (3). Idling cortical areas show repetitive waveforms,
mostly with a thalamic pacemaker (13). The aggregate current flow is scattered and decreased
on the way to the scalp, especially, as the high resistance of the skull decreases the current
flow.
Time domain EEG is the normal clinical presentation of the EEG, where voltage
changes (amplitudes) are presented over time. Changes in frequency (repetition rate of the
waveform) and amplitude of the EEG may be characterized by means of power spectral
analysis. The power spectrum of the EEG is calculated from selected segments (epochs) of
time domain EEG using fast Fourier transformation (FFT), a mathematical method, which can
be used to decompose EEG into its component sine waves. Theoretically, under ideal
conditions, the information content of the waveform is not changed by this transformation,
and an inverse Fourier transformation gives the original, complex waveform of the EEG. The
decomposed sine wave information can be presented as a distribution of power over
frequency, and distinctive figures can be calculated to describe this distribution. Spectral edge
frequency 95 refers to the frequency below which 95% of the power of such distribution is
found (14, 15). This kind of univariate descriptors of the EEG appear inadequate to describe
the behavior of EEG during anesthesia both in terms of anesthetic adequacy (15) and also
when trying to identify untoward anesthetic effects, such as spikes (pointed waveforms
standing out from the background and a duration of 20–70 ms), all of which are lost (16).
Therefore, techniques other than Fourier transformation are required to detect epileptiform
EEG. Time domain visual analysis, although cumbersome, is the gold standard. Automated
EEG analyzing systems for spike detection have been developed, as well (17, 18).
Even though the EEG was the first electronic monitoring technique in the operating
room (19), its use in clinical anesthesia monitoring until recently has been sparse.
EFFECTS OF GENERAL ANESTHETICS ON EEG
The changes in average frequency and amplitude of the EEG show certain similarities
with increasing doses of most inhalation anesthetics. Low doses cause an increase in the
power of the beta range (Table 1), especially in the frontal regions, and a decrease in the alpha
range, and the amplitudes are small. At this stage, also the eye movement artifact ceases.
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Increasing the anesthetic dose to a surgical level induces in EEG an average decrease in
frequency towards the theta and delta range while the amplitudes increase. With some general
anesthetic agents such as isoflurane, sevoflurane, and propofol, a further rise in dose will
induce a special EEG pattern, burst suppression. This is a pattern in which high amplitude
activity alternates with low voltage periods, usually not exceeding ± 5 µV. Any further
increase in the anesthetic dose results in electrical silence, suppression (amplitude < 5 µV).
Table 1. EEG frequency bands (20).
Band Range (Hz)
Delta (δ) < 3,5
Theta (θ) 4–7.5
Alpha (α) 8.0–13.0
Beta (β) > 13.0
BISPECTRAL INDEX (BIS)
In his thorough review of the BIS, Rampil explains its basic principles of development
and the mode of action (3). The bispectral index of EEG is a weighted sum of EEG
subparameters, containing time domain, frequency domain, and high order spectral
subparameters. It was created after long development in a stepwise fashion. A large EEG
database was collected from 1500 adult anesthesia EEG recordings along with concurrent
behavioral assessments. Several subparameters were calculated and statistically tested to
discover the ones correlating best with important clinical endpoints. These were entered into a
composite index, BIS. The recorded EEG is first filtered to exclude artifacts and then divided
into 2–s epochs. Epochs containing irreparable noise such as any blink artifact, are rejected.
From the time domain version of the epoch, the degree of burst suppression (burst suppression
ratio, BSR) is calculated as the sum of intervals of suppression (amplitude < 5 µV, at least 0.5
s long) divided by the epoch length. Additional artifact correction can be applied in the
presence of a wandering baseline. The epoch is then converted to the frequency domain after
Blackman windowing to reduce distortion from epoch−end artifacts. From the frequency
domain version of the same epoch, fast Fourier transformation (FFT) and bispectrum are
calculated. Two subparameters are derived: the beta ratio and the bispectral component, which
is the degree of bicoherence, i.e., phase coupling between FFT–derived primary frequencies.
The beta ratio is the logarithm ratio of two empirically derived power bands: log (P30–
47 Hz/P11–20 Hz). The bispectral component is the log ratio of the bispectrum (B) activity in two
frequency ranges, log (B0.5–47 Hz/B40–47 Hz). The BIS calculation algorithm weights the beta
ratio most heavily when the EEG has features referring to light sedation. The bispectral
component is dominant in the algorithm calculation during EEG activation (excitement phase
of anesthesia) and during the surgical level of anesthesia. BSR is used to detect deep
anesthesia. Because of all the necessary processing, the value represented on the monitor’s
front panel is the average value for the previous 30-60 s of data.
Balanced anesthesia refers to the state in which unawareness and unresponsiveness
(both motor and autonomic nervous system) prevail. The BIS monitors the unawareness
component of balanced anesthesia (4, 21), but does not predict hemodynamic response to
intubation (22). It is not reliable in predicting movement response to skin incision (23). This is
to be expected, if we accept the significance of the autonomous nervous system in creating
hemodynamic responses (24) and the spinal cord as the major site determining a reflex
movement response to surgical stimuli during anesthesia (1, 2). The BIS gets its data from the
EEG, which can detect only cortical events, not spinal or autonomous reflexes. The only
11
component of balanced anesthesia available for monitoring from the cortical level remains the
unawareness reflected by the typical EEG features of drug−induced anesthesia: absence of
beta–range, presence of high power delta–range, burst suppression, or suppression. The BIS
also includes information on the degree of phase coupling invisible from the unprocessed EEG
activity and noticed to increase with increasing depth of anesthesia (25).
HEMODYNAMICS
REGULATION OF HEART RATE AND BLOOD PRESSURE
Heart rate (HR) is controlled mainly by the autonomous nervous system (26). The
sympathetic system enhances, and the parasympathetic system inhibits the cardiac pacemaker,
the sinoatrial node. Changes in HR usually involve a reciprocal action of the two; HR
increases with a decrease in parasympathetic activity and an increase in sympathetic activity.
A decrease in HR results from the opposite activity. Due to the rapid breakdown of the
neurotransmitter (acetylcholine), the effects of vagal stimulation cease very quickly when
stimulation is discontinued. Contrary to this, the effects of sympathetic stimulation decay only
gradually when the stimulation stops. The onset of sympathetic stimulation results in steady–
state values of the heart rate much more slowly than do the inhibitory effects of vagal
stimulation.
The cardiac parasympathetic fibers originate in the medulla oblongata, in the dorsal
motor nucleus of the vagus, or in the nucleus ambiguus. The cardiac sympathetic fibers
originate in the intermediolateral columns of the upper five or six thoracic and lower one or
two cervical segments of the spinal cord. These autonomous pathways are under the control of
higher regions of the brain, such as hypothalamic, thalamic, and even cortical regions. In the
cerebral cortex, the centers regulating cardiac function are located mostly in the frontal lobe,
the orbital cortex, and the motor and premotor cortex. Stimulation of the midline, ventral, or
medial nuclei of the thalamus causes tachycardia.
The primary functional efferent unit of the sympathetic and parasympathetic nervous
system is a two–neuron motor pathway, which consists of a pre– and a postganglionic neuron.
The cell body of the preganglionic neuron is located in the CNS, and the cell body of the
postganglionic neuron in the autonomic ganglion. The afferent autonomic neuron forms the
afferent limb of the reflex arch.
The baroreceptor reflex leads to an inverse change in heart rate in the case of a sudden
change in blood pressure. Baroreceptors are located in the aortic arc and carotid sinuses.
Volatile anesthetics attenuate arterial baroreflex function.
Chemical control of the heart rate is minimal, but adrenomedullary secretion of
epinephrine and norepinephrine is increased in the type of situation that stimulates the
sympathetic nervous system.
Blood pressure is determined mainly by blood volume, peripheral vascular resistance
(PVR), and cardiac output (CO), which is the amount of blood pumped by the heart within
one minute. Peripheral vascular resistance is the mean blood pressure divided by the CO
(mean blood pressure = CO × PVR). The volume of blood ejected from one ventricle with one
heartbeat is the stroke volume (SV). Thus, CO can be expressed with the equation CO = HR ×
SV, and mean blood pressure = HR × SV × PVR. Volatile anesthetics decrease peripheral
resistance; sevoflurane is reported to affect the vessels by direct dilatation (27).
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MEASUREMENT OF BLOOD PRESSURE
Blood pressure can be measured noninvasively by an oscillometric method. A
noncompliant cuff containing an inflatable bag is wrapped around an extremity, usually an
arm. The inflatable bag lies between the cuff and the skin directly over the artery to be
compressed (usually the axillary artery). The artery is occluded by inflating the bag to a
pressure above the systolic arterial pressure. The pressure is then slowly released through a
valve, and an electrical pressure transducer detects pressure−changes when arterial flow starts
under the cuff as the pressure in the cuff falls to a level allowing arterial flow. This gives the
systolic pressure. The oscillation is greatest when blood pressure equals the cuff pressure,
which gives the mean arterial pressure. The diastolic pressure is measured when the
oscillation stops as the pressure in the cuff falls below the diastolic arterial pressure.
SEVOFLURANE
DEVELOPMENT
Sevoflurane (CH2F–O–CH(CF3)2) is a halogenated ether. This general anesthetic
inhalation agent was developed in the late 1960s in the USA (28). It was set aside for many
years for two disadvantages noted during phase–I trials. These disadvantages were
metabolism which releases fluoride ions and reactivity with the soda lime, producing
substances nephrotoxic in rats. In 1988 Maruishi Pharmaceuticals (Osaka, Japan) restarted the
investigations on sevoflurane. The results of clinical trials were good, and in 1990 sevoflurane
was approved for clinical use in Japan. In the same year American studies were initiated
again, and in 1992 Abbott Laboratories (Chicago, USA) licensed sevoflurane (28).
CARDIOVASCULAR RESPONSES
Heart rate
The initial human study in 1981 found no significant change in heart rate during 1–
hour exposure to 2% to 3% sevoflurane in oxygen (29). A stable heart rate during sevoflurane
administration at various concentrations has been found in many human studies since that time
(30-32). Contrary to these findings, however, some studies reported increases in heart rate
during inhalation induction in pediatric patients (33-35).
In animal studies results differ by species: in swine, heart rate remained unchanged
during sevoflurane administration (36), but in dogs a significant increase occurred (37).
Arterial blood pressure
Blood pressure responses to volatile anesthetics are a function of their effects on
cardiac output and on vascular resistance. Both of these are influenced by the direct effects of
the anesthetic on the heart and vascular smooth muscle, and by the indirect effects of the
anesthetic on the autonomous nervous system. Arterial systolic blood pressure declined an
average of 17% in an initial human phase–I study during 1–hour exposure to 2% to 3%
sevoflurane in oxygen (29). A dose–dependent decrease in blood pressure and peripheral
vascular resistance without significant changes in sympathetic nerve activity pointed to a
direct effect on vascular smooth muscle (27, 31).
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RESPIRATORY EFFECTS
Sevoflurane depresses ventilatory function in a dose–dependent manner, shown by an
increase in PaCO2 and lower minute ventilation (38). At 1.1 MAC, sevoflurane produced the
same degree of respiratory depression as halothane, and at 1.4 MAC, it produced more
profound respiratory depression than halothane (38). Sevoflurane was the anesthetic least
irritating to the airway and was considered to be the most suitable for inhalational induction of
anesthesia, when compared to enflurane, isoflurane, and halothane (39).
INHALATION INDUCTION
Vital capacity rapid inhalation induction (VCRII) is an induction method introduced
especially in connection with sevoflurane (40). In VCRII, the patient exhales to the residual
volume and then inhales a high concentration of anesthetic agent to the vital capacity,
reducing induction phase time. The non–pungency of sevoflurane makes it suitable for this
kind of maneuver. Comparing the VCRII technique with the conventional spontaneous
inhalation induction technique, each using 4.5% sevoflurane in nitrous oxide and oxygen, the
VCRII required only half the length of the conventional inhalation induction (54 s and 108 s,
respectively), and was not associated with cardiovascular instability (41). Excitement was
reported to be less with VCRII, which was therefore recommended. Comparing VCRII for
sevoflurane and halothane, induction time was shorter with sevoflurane (42).
Children
Sevoflurane has low (0.68) solubility in blood (43), facilitating rapid mask induction,
as first described by Haga et al. (44). The induction and intubation with high concentrations of
sevoflurane (4% or 6.4%) were investigated in 180 children of ages ranging from one to six
yr. In this first study of a high inspired sevoflurane concentration it was noticed that
convulsions occurred at an incidence reportedly as high as 6%. A significant increase in HR
was observed in another study where the inspired sevoflurane concentrations were increased
every five breaths and were 2%, 4%, 6%, and 7% (34). During sevoflurane induction with
incremental increases in concentration until a maximum of 7% was delivered, significantly
higher average heart rates and systolic blood pressures were seen with sevoflurane than with
halothane (45); this study reported excitement but no convulsions with sevoflurane mask
induction. With administration of rapid increases of gas concentrations, in increments of 1%
up to 7% for sevoflurane, induction was reported to be smooth and rapid but characterized by
increases in heart rate and systolic blood pressure up to 20% in the sevoflurane group (35).
Heart rate increased during sevoflurane induction in a study by Constant et al., comparing
different types of sevoflurane inhalation induction and halothane inhalation induction (46).
This EEG study reported no seizure–like activity. Increase in heart rate during sevoflurane
induction in children was seen also in the study by Viitanen et al. (47).
Adults
In a comparative study with sevoflurane and isoflurane, 46 volunteers breathed
approximately 1.7 MAC equivalents of either vapor (40) and exhibited no significant
differences in monitored cardiovascular, respiratory, and electrocardiographic variables. The
mean time for induction of anesthesia was significantly shorter with sevoflurane (120 s) than
with isoflurane (145 s). Increase in heart rate was observed in a study by Sloan et al. (48), in
which 50 patients received a single–breath induction with either 5.0% sevoflurane or 5.0%
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isoflurane in a 1:1 N2O/O2 mixture; induction times were similar for sevoflurane (75 ± 3 s)
and isoflurane (67 ± 4). Sevoflurane patients were less likely to have complications during
induction; coughing occurred more frequently with isoflurane. During induction, heart rate
increased with both drugs. Sevoflurane was thus concluded to be more suitable than isoflurane
for a single–breath induction.
CNS TOXICITY
In two of 13 cats receiving 5% sevoflurane, the cortical EEG showed spikes with
isoelectricity, and consequent repetitive peripheral electrical stimulation induced generalized
seizures (49). Many reports exist on similar influence in humans. A sevoflurane inhalation
induction study in children reported convulsions of 30 s duration at an incidence of 6% (44).
In a recent study in healthy volunteers, two out of eight had an EEG–verified seizure during
long sevoflurane monoanesthesia (50). In a scoliosis operation under 7% sevoflurane in O2 in
N2O anesthesia, the EEG was recorded and spike–and–wave seizure activity occurred for 30 s
(51). One case report describes tonic and clonic movements during sevoflurane inhalation
induction, and because they were sustained for 20 min despite the medication, anesthesia had
to be discontinued (52). Several reports have appeared on convulsive movements or
epileptiform EEG potentials during sevoflurane inhalation induction with high inspired
sevoflurane concentrations (53-55). Pediatric patients with epilepsy had, during sevoflurane
inhalation induction, EEG−verified generalized epileptiform discharges without visible signs
of seizure (56). Reversal of neuromuscular block at the end of sevoflurane anesthesia revealed
generalized tonic clonic convulsive–like movements in one healthy 32–year–old patient (57).
CNS TOXICITY OF INHALATION ANESTHETICS OTHER THAN
SEVOFLURANE
Neuroexcitatory movements have been reported in association with most of the
anesthetic inhalation agents. Both the proconvulsant properties and the anesthetic effects have
been hypothetized to depend on the degree of halogen substitution of the compounds (58).
ENFLURANE
Enflurane is probably the most widely recognized currently used anesthetic agent with
convulsive properties. Enflurane has induced EEG–verified, generalized, grand mal–type
seizures when given at high concentrations with hyperventilation of the patients (59).
Numerous reports of epileptiform EEG during enflurane anesthesia have appeared (60-62),
and its proconvulsant effects have been used in epilepsy surgery to detect the epileptic focus
(63). Heart rate increases during enflurane–induced epileptic discharge (64).
ISOFLURANE, HALOTHANE, DESFLURANE
Halothane and isoflurane are considered safe in respect to convulsions. Some case
reports of convulsive movements during halothane or isoflurane anesthesia exist (65, 66), but
lack of EEG verification makes evaluation of the origin of these movements difficult. When
EEG was recorded during induction of anesthesia with isoflurane, a seizure was recorded
during clinical convulsion (67). No epileptiform EEG was seen during hyperventilation with
1.24 MAC desflurane (68). Fluorinated ether with some anesthetic properties (fluorothyl) was
marketed in the 1960s as a proconvulsant drug alternative to electroconvulsive therapy (ECT)
(69).
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CNS–TOXICITY OF NON–INHALATIONAL ANESTHETIC AGENTS
Ketamine has convulsant properties when given to epileptic patients (70), and
generalized transient convulsions were reported in non–epileptic patients given ketamine (71).
Both alfentanil (50 µg/kg) and fentanyl (10 µg/kg) activate epileptiform activity in patients
with intractable temporal lobe epilepsy, and these opioids have been used to assist in the
localization of the epileptogenic focus during surgery (72). Propofol has been reported to
induce convulsive movements (73) but also to be suitable in treatment of status epilepticus
(74). Similar dose–dependent EEG effects were reported in a study with propofol in patients
with or without a history of seizure disorders. Whereas induction of anesthesia with higher
doses of propofol (> 1.5 mg/kg) in neurosurgical patients with seizure disorder under good
control was safe, one patient in the epileptic group had an EEG–recorded and clinical grand
mal seizure after propofol 1 mg/kg; the seizure disappeared, however, after an additional 0.5–
mg/kg bolus dose (75).
During electroconvulsive therapy (ECT), seizures were longest with methohexitone–
alfentanil and shortest with propofol in a study comparing these medications. The combination
of methohexitone with alfentanil was recommended in ECT in preference to propofol to
prolong seizure duration (76). A prospective study evaluated the effects of propofol sedation
on the incidence of intraoperative seizures during awake craniotomy performed for the
management of refractory epilepsy. Thirty patients were randomized to receive propofol or
neurolept analgesia along with fentanyl and droperidol, and a higher incidence of
intraoperative seizures occurred among the neurolept patients (6 vs. 0) (77).
EPILEPTOGENESIS
EXCITABILITY
The basic disturbance in generalized seizures is considered to be exaggerated cortical
excitability (78). Excitability is dependent on the balance between inhibitory and excitatory
impulses and the level of synchronization of neural networks. Depending upon whether
synaptic activity is of the excitatory or inhibitory type, the postsynaptic neuronal membrane
will be depolarized or hyperpolarized. Exitatory postsynaptic potentials (ESPSs) result when a
neurotransmitter released from a presynaptic terminal causes a net inward movement of
positive ions which depolarizes the cell. Inhibitory postsynaptic potentials (IPSPs)
hyperpolarize the postsynaptic membrane by causing a net outward ionic current that
increases the negative charge inside the cell (78).
The neuron is activated in a non–refractory phase. Additionally, a sufficient amount of
excitatory postsynaptic potentials (EPSP) must accumulate in relation to inhibitory
postsynaptic potentials (IPSP), to create an action potential. In a normal neuron population,
cells act in different phases, with only part of the population in a refractory phase. Under these
circumstances even a powerful excitatory torrent of impulses can activate only part of the
population. Conversely, an inhibitory impulse can block neurons despite their phase and
thereby synchronize a large population of neurons (79). Hypersynchronization is considered to
be the most important single mechanism in creating and spreading CNS irritation (80).
SEIZURE THRESHOLD
Seizure threshold is an individual feature, varying considerably interindividually (81).
It is affected by many factors such as age and gender (81), hormones (82), even diet (83).
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Seizures take place when neural tissue excitability exceeds the individual seizure threshold.
This fact is useful in the diagnostic activation of epileptic foci. In epileptic patients on
anticonvulsive therapy, sleep deprivation prior to EEG recording activates epileptiform
activity (84). The combination of the short sleep following 24 h of sleep deprivation, with
subsequent use of the additional provocative methods of hyperventilation, photostimulation
and hydration, was reported to yield new diagnostic information on epileptiform EEG in 50%
of the epilepsy patients (85). Other reported seizure–inducing mechanisms include intense
emotional stress, fever, hypoglycemia, hypocalcemia, hyponatremia, hypomagnesemia,
hypoxia, and hyperbaric states (86), some of which elicit seizures even in a non–epileptic
brain.
With ECT, seizure can be induced in anyone. Theophylline prolongs seizure duration
in ECT (87), and status epilepticus occurred after electroconvulsive therapy in a patient whit a
theophylline level above the accepted therapeutic range (88). Caffeine is also used to facilitate
ECT in therapy–resistant patients (89). Antimicrobial treatment with imipenem (90), and
immonusuppression with cyclosporin A, especially in connection with hypomagnesemia, (91)
have both been reported to relate to an increased risk of seizures. In an experimental animal
model, dexmedetomidine, a selective alpha2−agonist agent, decreased the convulsion
threshold (92). During presurgical evaluation, 14 patients with medically intractable focal
epilepsies underwent magnetoencephalographic recordings to localize the epileptogenic focus,
and demonstrated the selective proconvulsant effects of methohexital on their epileptogenic
focus (93). Clonidine also increased epileptiform activity in patients with seizure disorders.
High–dose dexmedetomidine was found in cats to reduce the seizure threshold during
enflurane anesthesia (94).
GAMMA–AMINOBUTYRIC ACID, GABA
GABAergic transmission of impulses in CNS is assumed to inhibit the excitative
phenomena (95). This main rule does not always, however, apply, as shown by the convulsive
effects of some GABAergic agents. Although sevoflurane and enflurane, like many other
volatile agents, have been shown to enhance GABAergic transmission (96, 97), deep
enflurane anesthesia combined with hyperventilation is known to elicit seizures (59). In the
flurothyl seizure model using adult rats, substantia nigra pars reticulata microinjection of the
selective GABA–A−receptor agonist muscimol results in a biphasic dose–response curve:
intermediate doses being anticonvulsant, but high doses having proconvulsant effects (98).
These changes were age–related. In younger animals, no anticonvulsant effects of muscimol
occur, only proconvulsant effects, and at lower doses than in adults. Direct GABA agonist
THIP (tetrahydroxyisoxazolopyridine) can be used to induce another animal model of
epilepsy, synchronous bilateral spike–and–wave activity (99).
KINDLING
Periodic administration of convulsive agents, even at doses or intensities that initially
have no convulsive effect, can lead to a progressive and enduring increase in susceptibility to
subsequent convulsive stimulation which is known as the kindling effect. Animal kindling
models have been used in research on epilepsy.
Analogous to experimental kindling are prolonged febrile seizures in childhood, or an
episode of status epilepticus at any age, which can produce the highly characteristic pattern of
hippocampal cell loss and shrinkage that is seen later in life, if patients develop temporal lobe
epilepsy. Seizure–induced and presumably excitotoxic pathology includes neuronal loss,
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reactive gliosis, aberrant synaptic reorganization of surviving cells, and hippocampal tissue
shrinkage that may alter extracellular space and affect ionic homeostasis (100).
The epileptic seizures seen during the alcohol withdrawal syndrome are often similar
to those seen in experimental epilepsy models such as kindling models (101). The chronic
consumption of alcohol, if consumption is interrupted abruptly, can lead to a withdrawal
syndrome, which is a state of hyperexcitability characterized by anxiety, fear, muscular
rigidity, and tonic–clonic seizures with epileptiform–type characteristics. A possible
correlation may exist between these models (101).
The susceptibility of pediatric patients to developing brain pathology in a kindling–like
process may be higher when compared to that of adults. Several factors may contribute to the
propensity for the developing brain to undergo seizures and develop epilepsy.
Hypersynchrony of neuronal circuits contributes to the seizure potential, and several
neurobiological features of the immature brain may support synchronized neuronal firing
(102). The immature cerebral cortex and hippocampus have a higher density of synapses than
that of adults and also a higher density of gap junctions and of excitatory amino acid receptors
(102). Enhanced regenerative responses to injury in the developing brain may also contribute
to the formation of abnormal hippocampal connections that support epilepsy. Molecular
mechanisms that contribute to enhanced synaptic plasticity in the child's brain can also in
certain circumstances contribute to epileptogenesis.
The phenomenon of kindling, in which repeated electrical stimulation of neuronal
circuits leads to the development of epileptic seizures, is easily elicited in young animals.
Long–term potentiation (LTP), in which repeated synaptic stimulation leads to a reduced
threshold for activation of that pathway and enhanced postsynaptic potentials, is much more
robust in the immature cerebral cortex and may contribute to kindling and epileptogenesis.
Age–related enhancement of N–methyl–D–aspartate–type glutamate receptors, important for
the activity−dependent plasticity in the developing brain, appears to participate in LTP. This
information suggests that normal developmental features of synaptic development make the
immature brain more excitable than the adult brain and may contribute to epileptogenesis
(102).
The mechanisms of epileptogenic potential of anesthetic agents are unknown.
Theoretically, in experimental circumstances a kindling–like effect may exist, for example
with repetitive administration of enflurane and hyperventilation and/or photic stimulation.
This, however, has not been researched.
MYOCLONUS
Myoclonus is a frequently reported phenomenon in the context of various anesthetic
agents. The term “myoclonus” originates from the Greek klonos, which refers to violent
movements; and the prefix “myo” originally was meant to distinguish these movements from
epileptic clonus (103). In the course of time, myoclonus has been connected with epileptic
movements as well, and epileptic myoclonus is now considered to be one category of
myoclonus (103). Without EEG recording, the exact nature of clonic movements is unclear.
Unfortunately, only a few studies reporting myoclonus during anesthesia include the results of
simultaneous EEG recording. Etomidate is reported to produce myoclonus in 45% of the
patients during cardioversion (104). A study comparing incidence of myoclonus with different
anesthetic agents reported myoclonic responses in 69% of the etomidate patients, of whom
22% had multiple spikes appearing on the EEG (105).
A healthy man developed nonconvulsive seizures and generalized paroxysmal fast
activity in his EEG following propofol anesthesia (106). An increase in heart rate and
excitatory movements during propofol infusion was reported in four patients (107). A report
18
of five patients with seizures in association with propofol anesthesia included a female
epileptic patient who developed severe status epilepticus (108). The other patients with short–
lasting seizures had no previous epilepsy. In a propofol induction study with a pediatric
patient population, propofol 3 mg/kg induced spontaneous dystonic and choreiform
movements in all seven patients but no EEG abnormalities (109). The safety of intravenous
methohexital for brief, unconscious sedation of pediatric hematology/oncology outpatients
undergoing painful invasive procedures was evaluated, and myoclonus was observed in 10%
(110). A small dose of alfentanil (5 µg/kg i.v.) was reported to decrease myoclonus induced
by methohexital anesthesia (105).
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AIMS OF THE STUDY
Effects of sevoflurane anesthesia on EEG and hemodynamics was studied. Specific
objectives of this thesis were:
1. To determine the sevoflurane requirement for adequate anesthesia during laparoscopic
tubal ligation (LTL), with the bispectral index of the EEG and hemodynamic responses
as criteria.
2. To evaluate the hemodynamic profiles in adults during sevoflurane inhalation
induction produced by different breathing modifications.
3. To examine EEG effects and their hemodynamic correlations with the sevoflurane
inhalation induction in adults during spontaneous breathing or controlled
hyperventilation.
4. To study the effects of delaying the rapid rise in sevoflurane concentration in adults by
allowing the patients to breathe spontaneously for two minutes before starting the
hyperventilation.
5. To compare in children the effects of spontaneous breathing and controlled ventilation
on EEG and hemodynamics during sevoflurane inhalation induction.
6. To compare the development of EEG features in adults versus children during
sevoflurane induction.
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PATIENTS AND METHODS
PATIENTS
The total number of patients in the present study was 159. The adult study population
comprised 127 females. The pediatric population comprised 32 children, 13 female and 19
male. Adult patients were scheduled for elective surgery in the Women’s Hospital, Helsinki
University Hospital. Children were scheduled for elective surgery in the Eye–Ear Hospital of
Helsinki University Hospital.
Study I was based on 32 ASA physical status I–II females who underwent LTL, and
Studies II–IV on 95 ASA I–II patients undergoing elective gynecological surgery. Study V
involved 32 ASA I–II children, aged 2–12 years, undergoing elective otolaryngolocical
surgery (Table 2).
Table 2. Characteristics of study patients.
Study Age (years)
Mean ± SD
Height (cm)
Mean ± SD
Weight (kg)
Mean ± SD
I 40 ± 4 168 ± 6 64 ± 8
II 38 ± 8 166 ± 5 62 ± 9
III 39 ± 6 166 ± 6 67 ± 9
IV 38 ± 7 165 ± 6 64 ± 9
V 6 ± 2 117 ± 18 24 ± 10
All studies were approved by the ethics committees of the hospitals (Women’s
Hospital and Eye-Ear Hospital, Helsinki University Hospital, Helsinki). All adult patients
gave their written informed consent before participation, and all the parents of the children
included in Study V gave preoperative written informed consent. Two adults in Study I were
excluded, one because of high BIS values, and the other due to increased arterial pressure after
endotracheal intubation. One child was excluded from Study V because of lack of
cooperation.
DESIGNS AND PROTOCOLS OF THE ORIGINAL STUDIES
Study I. The sevoflurane requirement, based on BIS and hemodynamic responses in
day–case surgery, was assessed. Knowing that unconsciousness in healthy volunteers (with no
surgery) is already achieved at 0.4 MAC, we tested the hypothesis that in surgical patients less
than 1 MAC sevoflurane can produce unconsciousness. Anesthesia was induced by VCRII
and maintained with sevoflurane in N2O and O2 (33%) in 32 women undergoing laparoscopic
tubal ligation (LTL). The sevoflurane dose was chosen to produce desired BIS levels within
agreeable limits of blood pressure and heart rate. For the first patient, the sevoflurane
concentration was adjusted to 1 MAC with an end–tidal concentration (ET) of 0.7%. BIS–
values were used to determine the concentration to be used for the next patient. If the BIS
values remained below 50 for over 50% of the operation time, the concentration of
sevoflurane was reduced so that the ET level fell by 0.1%. When the BIS values were greater
than 65 for over 50% of the operation time, ET sevoflurane concentration was increased by
0.1% for the next patient. BIS values between 50 and 65 were considered acceptable; thus
when the value remained between these limits for more than 50% of the time, no changes in
sevoflurane concentration were made for the subsequent patient. BIS values greater than 75
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for over 30 sec were treated with a propofol bolus, and the data collection was discontinued.
Hemodynamic responses were deemed excessive if increases in systolic arterial pressure were
over 30% and/or the increase from the baseline in heart rate was more than 50%. These
patients were treated with additional propofol. The data collection was discontinued, and the
next patient underwent deeper anesthesia.
Study II. Occasional hyperdynamic circulatory responses during inhalation induction
with high sevoflurane concentration were observed during Study I. To examine this further,
HR and blood pressure profiles of 30 adult patients during 8% sevoflurane inhalation
induction with either spontaneous breathing or controlled hyperventilation were compared.
The anesthetic induction began with the VCRII technique followed by either spontaneous
breathing or controlled hyperventilation, during which ETCO2 was maintained below 30
mmHg. A blood sample from the radial artery was drawn immediately prior to intubation for
blood−gas analysis. Sevoflurane concentration was maintained at 8% until the endotracheal
intubation and was reduced to 1% after that point. Another five patients were studied to
evaluate the effect of hyperventilation per se on the hemodynamics of an anesthetized patient.
These patients were anesthetized with a propofol bolus 3 mg/kg followed by propofol infusion
15 mg/kg/h. Patients were hyperventilated exactly like the patients in the controlled
ventilation group. Ventilatory and hemodynamic parameters were recorded at 1–min intervals
for nine min after the loss of consciousness, six min before and three min after the tracheal
intubation. Differences in ventilation types were compared by measuring VF, MV, and ET–
sevoflurane concentrations, and by blood gas analysis. Baseline values for hemodynamic
parameters were recorded prior to induction during preoxygenation.
Study III. Hyperdynamic circulatory response observed in Study II was researched
further in Study III. Epileptic seizures are known to induce an autonomous nervous system
response which increases heart rate and blood pressure. Study II was repeated with additional
four–channel EEG recording during the inhalation induction. Time domain analysis of EEG
phenomena during mask induction was performed off–line. No propofol group was included.
The relationships were calculated between percentage rise in HR and occurrence of
epileptiform EEG.
Study IV. The hypothesis was that avoiding a very rapid increase in end–tidal
sevoflurane concentration by delaying the onset of hyperventilation would influence the
appearance of epileptiform EEG patterns. Patients were hyperventilated after loss of
consciousness either immediately or after a two–minute period of spontaneous breathing
during sevoflurane mask induction. Sevoflurane concentration was maintained at 8% until
endotracheal intubation, and decreased to 1% after that. In both groups an ETCO2 below 4%
was the aim. Ventilation types were verified by measuring minute ventilation and by gas
analysis of a blood sample from the radial artery. Heart rate and blood pressure profiles were
compared. Ventilatory and hemodynamic parameters were recorded at 1–min intervals for
eight min after loss of consciousness, five min before and three min after tracheal intubation.
Baseline values for hemodynamic parameters were recorded during preoxygenation prior to
induction. Four–channel EEG recording was visually analyzed off–line by a neurophysiologist
unaware of the induction type.
Study V. The occurrence of epileptiform EEG and coinciding hyperdynamic responses
in children during 8% sevoflurane inhalation induction with either spontaneous breathing or
controlled ventilation were compared. After they became unresponsive to verbal commands,
manually controlled ventilation was started in the controlled ventilation group. End–tidal CO2
was observed and maintained between 4.3 and 5.3 kPa (= 32 and 40 mmHg). If apnea
occurred in the spontaneously breathing group, slow controlled ventilation was started after a
30−s waiting period. In patients who had to be assisted, ETCO2 was allowed to rise to
between 6.0 and 6.7 kPa (= 45 and 50 mmHg) to mimic sevoflurane–induced respiratory
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depression. Blood pressure and HR profiles were compared. A neurophysiologist unaware of
the induction type visually analyzed four–channel EEG recording off–line.
Table 3. Study designs and the main topics.
Number
of
patients
Design Part of the
anesthesia
studied
Ventilation EEG
monitoring
Other measurements Main topic
I 32 Prospective Induction,
operation,
awakening
Controlled,
ventilator
2−channel
bipolar,
frontal, BIS
HR, blood pressure,
interview to detect
intraoperative
awareness
BIS vs. MAC
II 35 Prospective,
randomized
Induction Controlled
vs.
spontaneous
none HR, blood pressure,
SpO2, blood−gas
analysis, VF, MV,
ET–sevo, intubation
conditions
Hemodynamics
during
spontaneous vs.
controlled
hyperventilation
III 30 Prospective,
randomized,
double−blind
EEG analysis
Induction Controlled
vs.
spontaneous
4−channel
bipolar,
frontotemporal
HR, blood pressure,
SpO2, blood−gas
analysis
Hemodynamics
and EEG features
in adults during
spontaneous vs.
controlled
hyperventilation
IV 30 Prospective,
randomized,
double−blind
EEG analysis
Induction Controlled
vs. 2 min
spontaneous
and
controlled
after 2 min
4−channel
bipolar
frontotemporal
HR, blood pressure,
blood−gas analysis,
SpO2,
Sevoflurane CNS
concentration
rising speed vs.
hyperventilation–
induced EEG
effects
V 32 Prospective,
randomized,
double−blind
EEG analysis
Induction Controlled
vs.
spontaneous
4−channel
bipolar
frontotemporal
HR, blood pressure,
SpO2,
Hemodynamics
and EEG features
in children during
spontaneous vs.
controlled
ventilation
METHODS
PREMEDICATION, MONITORING
All adult patients were premedicated with 5 mg oral diazepam. Children were
premedicated with oral midazolam 0.5 mg/kg, maximum dose 15 mg, and oral atropin 0.03
mg/kg, maximum dose 1 mg. Monitoring included heart rate (HR), electrocardiogram, pulse
oximetry (SpO2), end–tidal carbon dioxide (ET–CO2), end–tidal sevoflurane concentration
(ET–sevo), and blood pressure. Ventilatory and gas measurements were performed from the
ventilatory circuit at the connecting piece close to the face mask. All these data were collected
with a Datex–Ohmeda AS/3 Anesthesia Monitor (Datex–Ohmeda Div., Instrumentarium
Corp., Helsinki, Finland).
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ANESTHESIA
Anesthesia for all adult patients was started with VCRII from a face mask using 8%
sevoflurane in N2O and O2 in a rebreathing circle system containing a carbon dioxide absorber
and primed beforehand with sevoflurane. The patients were asked to exhale forcefully to the
residual volume, followed by a vital capacity breath with a face mask placed tightly over the
nose and the mouth; they were then asked to hold their breath as long as possible. Thereafter,
the patients were allowed to breathe normally until unconscious. Unconsciousness was
defined as loss of eyelash reflex and no response to verbal commands. After each became
unconscious, ventilation was conducted according to specific study protocols until intubation.
To facilitate intubation and to minimize muscle artifacts affecting the EEG,
rocuronium was used in Study I. After intubation, the sevoflurane vaporizer was adjusted to
1% in Studies II, III, and IV and to 2% in Study V. In Study I, sevoflurane was administered
according to a specific study protocol after intubation.
In five control patients in Study II, anesthesia was induced with a propofol bolus 3
mg/kg, followed by a propofol infusion 15 mg/kg/h.
In children, anesthesia was induced with a face mask (chosen to fit tightly according to
each patient’s size) with a Jackson–Rees anesthesia system. The children breathed
spontaneously until becoming unconscious. Ventilation was conducted according to the
specific study protocol until intubation.
O2:N2O was 1:2 in Studies I and V, 1:1 in Studies II, III, and IV. Fresh gas–flow rates
were nine l/min in Study I, ten l/min in Studies II, III, and IV and equal to the square root of
patient weight in kilograms in Study V.
EEG
EEG data were collected with an Aspect EEG monitor A 1000 (Aspect Medical
Systems, Natick, MA, USA) and Zipprep EEG electrodes (Aspect Medical Systems). Before
electrode placement, the skin was prepared with alcohol and abraded to ensure electrical
conductivity. A two–channel bipolar EEG was used to record the BIS during anesthesia and
surgery in Study I; four–channel bipolar EEG was recorded during induction of anesthesia in
Studies III–V. A four–channel EEG in Studies III–V was recorded from the following
electrode pairs: Fp1–left mastoid, Fp2–right mastoid, Fpz–left temporal, and Fpz–right
temporal. Prior to EEG recording, an impedance check was performed; impedance below 5
kΩ was considered acceptable. Time domain EEG recordings during induction of anesthesia
in adults were classified as delta (D), slow delta (DS), slow delta monophasic (DSM), slow
delta monophasic with spikes (DSMS), burst suppression (BS), burst suppression with spikes
(SBS), polyspikes (PS), rhythmic polyspikes (PSR), in studies III and IV and periodic
epileptiform discharges (PED) in Study IV (Fig. 1).
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Figure 1. EEG features classified in adults. Delta (D), slow (<2 Hz) delta (DS), slow delta
monophasic (DSM), slow delta monophasic with spikes (DSMS), burst suppression (BS),
burst suppression with spikes (SBS), polyspikes (PS), rhythmic polyspikes (PSR), and
periodic epileptiform discharges (PED).
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Similar classification during induction of anesthesia in children was: slow delta (DS),
delta (D), delta with spikes (DSP), burst suppression (BS), suppression with spikes (SSP),
rhythmic polyspikes (PSR), periodic epileptiform discharges (PED), and suppression (S)
(Fig. 2).
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Figure 2. EEG features classified in children.
Occurrence, appearance, and duration of EEG waveforms were calculated. All EEG
recordings were visually analyzed and classified by one blinded (= unaware of the induction
type of the anesthesia) neurophysiologist familiar with anesthesia EEG.
STATISTICAL ANALYSIS
To calculate the response rates of 50% and 95% in Study I, according to de Jong and
Eger (111), a logistic model was applied (112) (S–Plus 4.0, MathSoft Inc, Seattle, WA, USA)
to estimate the appropriate doses of sevoflurane. Hemodynamic parameters were analyzed
with analysis of variance for repeated measures, followed by paired t–tests for comparisons in
changes in MAP and HR within a group, and unpaired t–tests between groups SB and CV as
post hoc tests (II–V). The Mann–Whitney U–test was used to compare the similarities
between the study groups by ASA class in Study II. The occurrence of epileptiform EEG
according to induction type was analyzed by Fisher exact test (III–V). The differences in
appearance and duration of EEG waveforms between induction types were analyzed with
unpaired t–tests. Statistics were analyzed with GB–Stat™ V6.5 (Dynamic Microsystems, Inc,
Silver Spring, MD, USA) and with the Statistical Package for the Social Sciences (SPSS),
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Windows version 6.0.1 or 9.0 (SPSS Inc., Chicago, IL, USA). P < 0.05 was considered
statistically significant. Parametric data are presented as mean ± SD.
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RESULTS
SEVOFLURANE REQUIREMENT IN LTL (AIM 1)
The ET sevoflurane concentrations required to keep BIS values at the 50 to 65 level
ranged from 0.7 to 0.9%. The ET sevoflurane concentration required was 0.7% in five
patients, 0.8% in 20, and 0.9% in five (Figure 3).
Figure 3. Sevoflurane concentrations required to maintain BIS between 50 and 65 during
LTL. X = The two patients excluded from the study.
The ED50 for adequate sevoflurane (with N2O) anesthesia during LTL was 0.7%
ET sevoflurane (CI 95% 0.63–0.77). The ED95 was 0.83% ET sevoflurane (0.75–0.90). Very
low BIS values were recorded immediately after the mask induction, whereas the patients’
BIS responses varied somewhat during surgery. The hemodynamic and BIS values recorded
during the study are presented in Figure 4.
Figure 4. BIS values, heart rate (HR, b.p.m.), and mean arterial pressure (mmHg)
preoperatively (preop), before intubation (preint), three and six min after intubation, at skin
incision (inc), and until nine min after incision.
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HEMODYNAMICS DURING SEVOFLURANE ANESTHESIA (AIM 1)
The hemodynamic profile during BIS−guided anesthesia for LTL is shown in Figure 4.
Both heart rate and MAP were stable. An occasional increase in heart rate was observed
within the first three min of VCRII induction of anesthesia with sevoflurane.
HEMODYNAMICS DURING SEVOFLURANE INDUCTION (AIMS 2 AND
5)
HEART RATE
In adults, heart rate increased during controlled hyperventilation from the preinduction
baseline, and remained at baseline level during spontaneous breathing (Fig. 5a). When
controlled hyperventilation was applied after two min of spontaneous breathing in Study IV,
heart rate increased more slowly than during induction with immediate onset of
hyperventilation. In children, controlled ventilation and spontaneous breathing both increased
heart rate (Fig. 5 b).
Figure 5 a. Heart rate during 8% sevoflurane induction in adults. Controlled hyperventilation
(CV) in Studies II, III, and IV provoked a significant increase in heart rate (left histogram).
* P < 0.001 within group compared to baseline. 0 = preinduction value. Spontaneous
breathing (SB) during 8% sevoflurane induction maintained HR at baseline level.
Figure 5 b. In children (V), contrary to adults, spontaneous breathing (SB) also increased
heart rate from baseline, although not as much as did controlled ventilation. # P < 0.05,
¤ P < 0.01, * P < 0.001 within group compared to baseline. 0 = preinduction value.
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BLOOD PRESSURE
In adults, during controlled hyperventilation blood pressure increased from (III, IV), or
remained at baseline level (II). During spontaneous breathing, MAP decreased from baseline
level (II, III) (Fig. 6). In children (V), blood pressure increased initially during controlled
ventilation and decreased after three min from the beginning of unconsciousness. During
spontaneous breathing, blood pressure decreased after four min from the beginning of
unconsciousness (Fig 6).
Figure 6. Mean arterial pressure during 8% sevoflurane induction. Controlled
hyperventilation (CV, CH) in Studies II and III caused MAP to remain at a higher level than
with spontaneous breathing in adults. In children (V), an initial increase in the controlled
ventilation group soon turned into a decrease. In Study IV in adults, starting the controlled
hyperventilation after two min of spontaneous breathing (D) prevented decrease in blood
pressure. Immediate onset of hyperventilation after loss of consciousness (I) increased the
blood pressure from the baseline in Study IV. # P < 0.05 value higher than baseline.
∀ P < 0.05, lower than baseline. // P < 0.01, value lower than baseline. [ P < 0.001, value
lower than baseline.
SEVOFLURANE–INDUCED EEG WAVEFORMS DURING
INDUCTION (AIMS 3 AND 5)
The evolution of EEG features during anesthetic induction with the 8% sevoflurane–
N2O–O2 mask started with changes in eye movements: the slowing of saccadic eye
movements and cessation of blinks. This was accompanied by an increase in beta (> 13 Hz)
range activity. In a few seconds, slowing of the EEG took place. The dominant frequency
changed to theta (4 – 8 Hz) and further to delta activity (Figs. 1 and 2). At this point, the EEG
recordings began to show epileptiform activity, predominantly in the groups with controlled
hyperventilation. Periodic epileptiform EEG features occurred mainly in these groups. Milder,
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non–periodic epileptiform EEG features (spikes and polyspikes without rhythmicity) occurred
frequently also in the spontaneously breathing groups. In many adult patients breathing
spontaneously, monophasic slow delta with or without spikes continued to the end of the
study.
SEVOFLURANE−INDUCED EPILEPTIFORM EEG APPEARING ONLY IN ADULTS
Slow monophasic delta with spikes (Fig. 7) occurred in five (33%) patients in the
controlled hyperventilation group and in four (27%) in the spontaneous breathing group in
Study III (n.s.) and in four (27%) patients in the immediate hyperventilation group and in one
(7%) in the delayed hyperventilation group in Study IV (P < 0.05).
*2s
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Figure 7. Slow monophasic delta with spikes. Notice the spikes (*) on top of the downward
deflecting delta waves.
Polyspikes (Fig. 8) occurred in 13 (87%) patients in the controlled hyperventilation
group and in six (40%) in the spontaneously breathing group (III) (P < 0.05) and in 14 (93%)
patients in both groups in IV (n.s.).
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Figure 8. Polyspikes.
Burst suppression with spikes (Fig. 9) was recorded in the controlled
hyperventilation group in Study III, in three (20%) patients (n.s. between study groups). In
Study IV, two patients (13%) in the immediate hyperventilation group and five (33%) in the
delayed hyperventilation group showed burst suppression with spikes (n.s.).
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Figure 9. Burst suppression with spikes.
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Figure 10. Burst suppression with spikes (upper trace) and burst suppression (lower trace)
from the same patient.
SEVOFLURANE−INDUCED EPILEPTIFORM EEG APPEARING ONLY IN CHILDREN
Mild epileptiform EEG (delta with spikes) (Fig. 11) were present in 15 patients (94%)
in the controlled ventilation group and in 12 (80%) in the spontaneous breathing group (n.s.).
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Figure 11. Delta with spikes. Notice the amplitude scale differing from the other EEG traces.
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Suppression with spikes (Fig. 12) was present in four patients (25%) in the controlled
ventilation group, and in none in the spontaneous breathing group (n.s.).
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Figure 12. Suppression with spikes.
SEVOFLURANE−INDUCED EPILEPTIFORM EEG APPEARING BOTH IN ADULTS AND IN
CHILDREN
Rhythmic polyspikes (Fig. 13) occurred in 13 (87%) patients in the controlled
hyperventilation group and in one (7%) in the spontaneous breathing group in Study III (P <
0.01). In that patient, HR increased from 62 to 88 beats/min three min after the beginning of
induction. In Study IV, 11 (73%) patients in the immediate hyperventilation group and six
(40%) in the delayed hyperventilation group showed rhythmic polyspikes. In children, seven
patients (44%) in the controlled ventilation group and three (20%) in the spontaneous
breathing group showed periods of rhythmic polyspikes in their EEGs (n.s.).
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Figure 13. Rhythmic polyspikes. Upper trace from an adult patient, lower from a child.
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Periodic epileptiform discharges (PED) (Fig. 14) appeared in Study III in ten
patients (66%) in the controlled hyperventilation group and in one (7%) in the spontaneous
breathing group (P < 0.01). In that study they were not classified separately, but were included
in the PSR group. PED appeared in ten patients (66%) in the immediate hyperventilation
group and in five (33%) in the delayed hyperventilation group in Study IV (P = 0.07). In
children (Study V), PED appeared in seven patients (44%) in the controlled ventilation group,
and in none in the spontaneous breathing group (P < 0.01).
2s
-
200µV
+
Figure 14. Periodic epileptiform discharges. Upper trace from an adult patient, lower from a
child.
HEMODYNAMIC RESPONSE IN CONNECTION WITH
EPILEPTIFORM EEG (AIMS 3 AND 5)
In adults, the incidence of epileptiform EEG was high and heart rate and blood
pressure both increased from the baseline level in the ventilated groups (Table 4). In the
spontaneously breathing adult group, the incidence of epileptiform EEG was low, and heart
rate remained at the baseline level while the blood pressure decreased.
In children, the incidence of epileptiform EEG was high, and heart rate increased from
the baseline in the ventilated group. Blood pressure reached its peak at one min, but decreased
after three min. In the spontaneously breathing pediatric group, the incidence of epileptiform
EEG was moderate and so was the increase in heart rate. Blood pressure decreased after four
min.
Table 4. P = differences within each group compared to the baseline.
Study Ventilation
type
Combined
incidence of PSR,
PED and SSP (%)
Highest change in
heart rate (%)
Highest change in
blood pressure (%)
III Ventilated 87 + 55 (P<0.001) + 17 (P<0.05)
IV Ventilated 73 + 77 (P<0.001) + 16 (P<0.05)
V Ventilated 88 + 63 (P<0.001) – 27 (P<0.001)
III Spontaneous 7 + 9 (n.s.) – 15 (P<0.01)
V Spontaneous 20 + 30 (P<0.01) – 22 (P<0.001)
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THE EFFECTS OF DELAYING THE RAPID RISE IN
SEVOFLURANE CONCENTRATION (AIM 4)
Incidence of epileptiform EEG was moderate (40%) with the delayed onset of
hyperventilation. This was accompanied by an increase in heart rate of 26% (P<0.05) and a
blood pressure level remaining at baseline. This hemodynamic response was clearly less than
with the immediate onset of hyperventilation (Table 4, Study IV), but the hemodynamic
parameter values (as well as the incidence of epileptiform EEG) were higher than with
spontaneous breathing throughout the whole induction (Table 4, Study III, spontaneous
group).
DIFFERENCES BETWEEN ADULTS AND CHILDREN (AIM 6)
In general, with a similar sevoflurane anesthetic induction and a similar EEG recording
technique, amplitudes were much higher in children. The order of the appearance of delta
differed between adults and children: in adults after beta the frequency gradually slowed to
delta below 4 Hz, and further to delta below 2 Hz. In children delta appeared in reverse order:
first after beta a sudden change to slow 0.5 to 2 Hz delta typically took place, and after that the
frequency gradually increased to 2 to 4 Hz. Burst suppression was the deepest anesthesia level
reached in adults; no adult patient showed suppression in the EEG during five or six min
induction, whereas in children suppression was detected in 61%. Besides plain beta, theta, and
delta, waveforms occurring in both adults and children during 8% sevoflurane induction were
rhythmic polyspikes, periodic epileptiform discharges, and burst suppression (Fig. 15).
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Figure 15. Burst suppression. Upper trace from an adult patient, lower from a child. Notice
the typical amplitude difference.
In children, three different types of interictal epileptiform EEG patterns were detected.
These were suppression with spikes, rhythmic polyspikes, and periodic epileptiform
discharges. Interictal epileptiform EEG patterns were present in 88% of the children
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undergoing controlled ventilation and in 20% of those with spontaneous breathing (P <
0.001). Suppression was common in children: 11 (69%) in the controlled ventilation group
and 8 (53%) in the spontaneous breathing group developed suppression (n.s.). Suppressions
occurred mostly after PED or other irritative waveforms, but exceptions were noted, such as
suppression straight after delta.
In adults, two different interictal epileptiform EEG patterns occurred: rhythmic
polyspikes and periodic epileptiform discharges. In all, interictal epileptiform EEG was seen
in 14 (93%) patients in the controlled hyperventilation group and in one (7%) in the
spontaneous breathing group in Study III (P < 0.001). In Study IV, the total incidence of
interictal epileptiform EEG was 11 (73%), and six (40%) with immediate and delayed onset of
hyperventilation (n.s.).
Two 8−min EEG recordings from adults and two 6−min EEG records from children
are shown in Figures 16–19.
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Figure 16. EEG during 8% sevoflurane induction in an adult. Eight min of EEG is presented
in four 2–min sections. Three 10–s samples are indicated with horizontal bars. 1. Polyspikes.
2. Rhythmic polyspikes. 3. Periodic epileptiform discharges.
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Figure 17. EEG during 8% sevoflurane induction in an adult. Eight min of EEG is presented
in four 2–min sections. Three 10–s samples are indicated with horizontal bars. 1. Rhythmic
polyspikes. 2 and 3. Periodic epileptiform discharges.
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Figure 18. EEG during 8% sevoflurane induction in a pediatric patient. Six min of EEG is
presented in two 3–min sections. Three 10–s samples are indicated with horizontal bars. 1.
Slow (< 2 Hz) delta. 2. Delta (2–4 Hz). 3. Periodic epileptiform discharges and the beginning
of suppression.
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Figure 19. EEG during 8% sevoflurane induction in a pediatric patient. Six min of EEG is
presented in two 3–min sections. Three 10–s samples are indicated with horizontal bars. Delta
with spikes turning into rhythmic polyspikes. 2. Periodic epileptiform discharges and the
beginning of suppression with spikes. 3. Suppression with spikes.
JERKING MOVEMENTS DURING SEVOFLURANE INDUCTION
Two patients in the controlled hyperventilation group in Study II had jerking
movements of the shoulders and upper arms at three to five minutes after the start of
inhalation anesthesia. Similar movements were seen in four patients with controlled
hyperventilation in Study III. Three of these expressed jerking movements of the shoulders,
biceps, or arms, and bilateral plantar flexion was seen in one patient. Movements began at one
to two min after the first inhalation of sevoflurane, and were associated with slow delta EEG
activity with or without spikes. Polyspikes or rhythmic polyspikes were seen later on in all the
patients experiencing movement. Two patients with immediate onset of hyperventilation
presented jerking movements in Study IV. One of these patients had twitches in all
extremities, with slow monophasic delta with spikes turning into polyspikes in the EEG, and
the other had twitches in the shoulders while the EEG showed slow monophasic delta with
spikes. In both these patients, EEG shortly proceeded into periodic epileptiform discharges.
None of the children showed jerking movements during sevoflurane inhalation induction
(Study V).
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DISCUSSION
METHODOLOGY
ANESTHETIC TECHNIQUE
Benzodiazepine premedication was used in all studies according to the clinical practice
of the Women’s Hospital and the Eye-Ear Hospital of the Helsinki University Hospital, where
the studies were performed. This, however, may have obscured the EEG effects of 8%
sevoflurane inhalation induction in Studies III, IV, and V. Omitting premedication from a
group of patients might have been informative, but would possibly have led to an increased
risk for epileptic events.
The VCRII method (= single–breath method) used in all adults was in line with the
recommendations of the manufacturer of sevoflurane, modified only with hyperventilation in
the hyperventilated groups in Studies II, III and IV (113). Moderate hyperventilation is
common clinical practice in the induction phase of anesthesia. Its purpose may be to ensure
good preoxygenation prior to intubation, and to lower CO2 level moderately to compensate for
the inevitable period without ventilation required to intubate the patient. Some
anesthesiologists hyperventilate the patient to speed up the induction phase.
ANESTHETIC ADEQUACY
Anesthetic adequacy in Study I was evaluated by use of the BIS, which is designed to
monitor the hypnotic effect of anesthetics (114). The BIS monitor is reported to be reliable in
detecting unconsciousness, especially at the conventional clinical level of anesthesia (115).
During very light levels of anesthesia, other monitoring means, such as the auditory evoked
potentials, may be superior for the detection of unawareness (116). Adequacy of analgesia was
monitored indirectly as absence of excessive hemodynamic responses. Anesthesia in Study I
was considered to be adequate when unconsciousness (BIS < 65) was reached, and
unnecessary deep levels (BIS < 50) were avoided to ensure quick recovery from day–case
surgery. An earlier report suggested that BIS values below 75 result in only a small possibility
of free (explicit) recall (21). Contrary to that, implicit memory formation has been reported to
be significant still at BIS levels between 40 and 60 in trauma patients anesthetized with
etomidate, isoflurane, and fentanyl (117). However, the significance of implicit memory
formation during anesthesia is unclear, and its possible consequences are unknown (118). No
testing for implicit memory formation was performed in our study.
EEG
The same equipment and the same montage was used for the EEG recording in adults
and in children. The quality of EEG records was good; eyeblinks and EMG artifacts ceased
early on nor, during the induction phase of the anesthesia, had surgical interference
(diathermia) yet begun. Sevoflurane induction studies were double−blind in regard to the EEG
analyses.
Most of the children developed apnea during spontaneous breathing. Although they
were ventilated distinctly less than was the controlled ventilation group, EEG features may
have been affected by this interference.
EEG was recorded from the frontotemporal regions in Studies III to V. In two of eight
healthy volunteers undergoing a study trial under 2 MAC sevoflurane anesthesia, epileptiform
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EEG was found in the frontal leads simultaneously with an EEG discharge in the
occipitotemporal region (50). Multichannel EEG covering the whole skull might have
revealed local EEG events in Studies III to IV. Our EEG recording system (Aspect A 1000
EEG Monitor, Aspect Medical System) is designed to collect data with EEG electrodes
(Zipprep, Aspect Medical Systems) which can be used in non–hairy regions only. Therefore,
no occipital or parietal EEG was included.
HEMODYNAMIC MONITORING
Heart rate and blood pressure were not monitored blinded, but automatically with an
AS/3 Anesthesia Monitor (Datex–Ohmeda Division, Instrumentarium, Helsinki, Finland).
Heart rate was calculated automatically from the ECG lead II. Blood pressure measurements
were non–invasive, with the cuff adjusted to patient size, as appropriate.
HEMODYNAMICS AND SEVOFLURANE
DURING LTL UNDER SEVOFLURANE ANESTHESIA (AIM 1)
Anesthesia with sevoflurane and nitrous oxide as sole anesthetics provided
hemodynamically sufficiently stable anesthesia. However, BIS does not predict intraoperative
hemodynamic responses (4). BIS–monitoring in our study demonstrated that hyperdynamic
circulatory responses, which are mediated by the autonomic nervous system, are poor
indicators of impending intraoperative awareness. In our patients, the largest hyperdynamic
response was measured in the presence of a low BIS, and the highest BIS during a modest
hyperdynamic response (Study I). We measured high arterial pressures in one patient after
endotracheal intubation. It is possible that the 3−min induction time was not sufficient to
prevent the circulatory response to intubation in this patient, even though a BIS value around
40 suggested that the patient was unconscious.
It is a common misunderstanding that rising arterial pressure and/or heart rate are
tokens of impending awareness. Although this can occasionally be the case, these are far more
frequently autonomic reflexes not related to awareness, and best blocked with opioids and
antihypertensive drugs. In an animal experiment, a 2.5−fold higher concentration of isoflurane
was required to prevent cardiovascular response to noxious stimuli when delivered selectively
to the brain, compared to the concentration required when delivered to the whole body (24).
This implies that the action of isoflurane in the brain has little to do with such a response.
Clinically meaningful concentrations of isoflurane were unable to prevent cardiovascular
responses in humans to noxious stimuli (119). BIS seems to be a reliable and easy method for
selective monitoring of the sleep component of anesthesia, whereas specific monitoring of
analgesic adequacy during anesthesia is yet to come. Inadequate analgesia can often be
indirectly identified from cardiovascular instability, but this is inaccurate and can be
misleading. In our study, 1 MAC sevoflurane in 66% N2O in O2 was sufficient to keep BIS
values below 65 and to prevent explicit memory and provide satisfactory hemodynamics
during laparoscopic tubal ligation in 95% of the patients.
DURING SEVOFLURANE INDUCTION (AIMS 2 AND 5)
Induction of anesthesia with 8% sevoflurane in N2O in O2 with controlled
hyperventilation produced a marked hyperdynamic circulatory response both in adults and in
children. Previously, hyperdynamic circulatory responses during sevoflurane induction have
been reported in children (34, 35). Rapid increases in isoflurane (120) and desflurane (31)
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concentrations have been shown to increase heart rates and blood pressures. Inhaled induction
of anesthesia with enflurane also increased heart rate (121). With enflurane, desflurane, or
isoflurane, airway irritation has been offered as an explanation for the hyperdynamic
responses observed (120-122). Airway irritation is not likely, however, to contribute to
sevoflurane–induced hyperdynamic response, as sevoflurane is non–pungent and has been
found to be the least irritant anesthetic to the airways when compared to halothane, enflurane,
or isoflurane (39).
Heart rate increased after loss of consciousness, which excludes anxiety from the list
of possible explanations for this increase. Induction was initiated by the VCRII method,
providing rapid loss of consciousness: 51 ± 17 s in adults (Study IV) and 41 ± 9 in children
(Study V). Increase in heart rate after these time–points is very unlikely to be result from
anxiety.
Pain–induced sympathetic stimulation is one common cause of increasing heart rate
during surgery. The induction phase studied in this thesis was, however, pain−free, as no
manipulation other than mask ventilation occurred.
Controlled hyperventilation was used in Studies II, III, and IV. Hyperventilation
during anesthesia as such does not increase heart rate or blood pressure, whether or not
hypocapnia is present (123, 124). Instead, hypercapnia increases heart rate in various types of
anesthesia (125).
In a majority of patients, epileptic seizures increase heart rate (126-128). The
acceleration of heart rate is greater in patients under 25 years old than in those over that age
(126). Ictal tachycardia has been suggested to depend on the volume of cerebral structures
recruited into a seizure (129). A similar hyperdynamic response occurs during electrically
induced seizures (130). During anesthesia, both epileptic discharges (64) and
electroencephalic transients (131, 132) have been found to increase heart rate.
During controlled hyperventilation with sevoflurane, blood pressure increased either
non–significantly or only initially, decreasing sooner than heart rate. This can be due to the
direct vasodilatory effect of sevoflurane (27). With increasing tissue concentrations of
sevoflurane, direct vasodilatory action may have dominated the central sympathetic
stimulation.
With spontaneous breathing, heart rate remained at the baseline level in adults but
increased in children. Blood pressure decreased from the baseline in adults, but an initial
increase occurred in children. This has been seen in other studies as well (34, 35).
In adults, controlled hyperventilation during 8% sevoflurane induction in N2O and O2
provokes hyperdynamic circulatory responses. Spontaneous breathing during similar
sevoflurane induction maintained heart rates at the baseline level but decreased blood
pressures.
CONNECTION OF HEMODYNAMICS AND EPILEPTIFORM EEG
(AIM 3)
The hyperdynamic response was in proportion to the incidence of epileptiform EEG
(Table 4). Rhythmic and periodic epileptiform EEG patterns were seen in patients with a
hyperdynamic circulatory response but polyspikes appearing without rhythmicity in adults
were not connected to such a response. Increase in hemodynamic variables refers to the
seizure–like nature of rhythmic and periodic patterns (133). Anesthesia induction with 8%
sevoflurane in N2O and O2 elicited epileptiform EEG patterns in adults during both controlled
hyperventilation and spontaneous breathing. The incidence of epileptiform EEG was
significantly higher with controlled hyperventilation, and rhythmic polyspikes (PSR) and
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periodic epileptiform discharges (PED) coincided with hyperdynamic circulatory responses in
adults.
HYPERVENTILATION (AIM 4)
Awake hyperventilation induces slow waves in the EEG (134). Hyperventilation–
induced EEG changes are not directly related to reduced cerebral blood flow (CBF) (135) or
hypoxia (134) but more likely to metabolic changes. Hyperventilation reduces serum
potassium concentration, which is directly proportional to arterial carbon dioxide tension
(136). Serum calcium concentration also decreases during hyperventilation (137). These
electrolyte disturbances could have had an epileptogenic effect and contributed to the
abundant epileptiform EEG found in our studies.
Hyperventilation during anesthesia with 1% halothane causes a greater reduction in
CBF than does awake hyperventilation (138). However, absolute CBF during anesthesia was
greater than awake, because anesthesia increased normocapnic CBF. Sevoflurane has been
reported to preserve CBF better than isoflurane during hypocapnia (139). Time–mean middle
cerebral artery flow velocity was unchanged when awake and during 1.2 MAC sevoflurane
N2O anesthesia. The cerebrovascular CO2–reactivity and autoregulation were well maintained
during 1.2 MAC sevoflurane with and without 60% nitrous oxide (140). Therefore,
hypocapnia is not likely to produce greater vasoconstriction during inhalation anesthesia than
when awake. Increased normocapnic CBF during inhalation anesthesia results in greater
absolute values in CBF during hypocapnia under anesthesia than during awake hypocapnia.
Therefore, reduced CBF to the extent of deficient oxygen supply to the brain is not a feasible
explanatory mechanism for the epileptiform EEG in Studies III to V.
However, hyperventilation is commonly used in the diagnostic activation of epileptic
phenomena during epilepsy diagnostics, especially in the activation of absence seizures. It is
therefore probable that hyperventilation has epileptogenic properties additive to those of
sevoflurane itself. This could explain the finding in Study IV, where hyperventilation
increased the incidence of periodic and rhythmic epileptiform EEG patterns also when started
after a delay of two min, when compared to the incidence of these patterns during spontaneous
breathing in Study III. Delaying the onset of hyperventilation by two minutes decreased the
incidence of PED by 50% (P = 0.07).
DEVELOPMENT OF EEG PATTERNS DURING SEVOFLURANE
INDUCTION (AIM 6)
Blinks ceased early in the beginning of induction, and EMG artifact was seldom
present. These are distinct advantages compared with awake EEG recording. Development of
delta during sevoflurane inhalation induction in children has a different pattern from that of
adults. Typically slower (< 2Hz) delta developed first after a short period (few seconds) of
beta activity and then turned into 2 to 4 Hz delta. Sevoflurane inhalation induction in adults at
a high inspired concentration produced the opposite order of appearance of delta: first, faster 2
to 4 Hz delta appeared and gradually slowed to < 2 Hz delta. Burst suppression occurred more
often in children (29%) than in adults (in 17%). Suppression, which was not observed in
adults during sevoflurane mask induction, occurred in most children (61%). Suppression often
occurred without preceding burst suppression.
The EEG events during similar sevoflurane induction differed between adults and
children in the order of the development of delta patterns. The incidence of EEG suppression
was over 50% in children whereas none of the adult patients developed suppression. In
children, amplitudes of EEG were higher.
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NITROUS OXIDE
Nitrous oxide is known to activate the EEG during burst suppression (141), but the
effect on interictal spikes during anesthesia is insignificant even in epileptic patients (142).
The role of N2O in eliciting the epileptiform EEG observed is, therefore, assumed to be
insignificant. In addition, the presence of N2O may attenuate brain CO2 reactivity.
Hyperventilation during isoflurane anesthesia with N2O has been reported to attenuate CO2
reactivity when compared to a MAC–equivalent anesthesia with isoflurane in oxygen (143).
However, since nitrous oxide was used in all the original studies included in this thesis, the
effect on EEG of sevoflurane inhalation induction omitting N2O remains speculative.
PERIODIC EPILEPTIFORM DISCHARGES
PED has been recorded preceding generalized seizure under deep sevoflurane
anesthesia (51). It resembles very much the spike–and–wave activity recorded by Rosén et al.
(59) preceding generalized seizure of grand mal type under deep enflurane anesthesia and
hyperventilation. Sevoflurane induces spikes with isoelectricity in the EEG in cats (49, 144)
resembling the PED found in our study. The incidence of spikes in cats increased with
increasing concentrations of sevoflurane, and during 5% sevoflurane anesthesia, peripheral
electrical stimulation induced GM seizure in cats (49). Thus, this EEG waveform can be the
final step before generalized seizure with convulsions. To study sevoflurane–induced PED
further, cats could serve as a suitable animal model. A subject of interest would be the
possibility of creating in cats a kindling model with repetitive sevoflurane administrations.
Sevoflurane is a GABAergic agent (145). In general, enhancement of GABA functions
results in an anticonvulsant effect (146). However, GABAergic activity can be excitatory
when the GABA synapse inhibits an inhibitory cell, the result being disinhibitory (147).
Inhibitory interneurons of the hippocampus are synchronized by each other (148). Excessive
activation of GABA–A receptors in the limbic structures can produce an occurrence of
synchronous GABA–mediated potentials (149). These may initiate seizures in rats (150).
GABA may also influence in a proconvulsant manner by synchronizing excitatory circuits
(151). Systemic administration of GABA–agonists resulted in a marked exacerbation of
spike–and–wave discharge duration in a genetic petit mal model (152). Fariello and Golden
describe an experimental spike–and–wave model in rats induced by intraperitoneal
administration of direct GABA–agonist THIP (tetrahydroxyisoxazolopyridine) (99). Enflurane
is also a GABAergic agent (153), yet well known for its ability to induce seizures (59).
On the other hand, the identical waveform repetition and regular intercomplex interval
typical of sevoflurane–induced PED are rarely seen in EEG recordings except during petit mal
(absence) seizures. In the absence status epilepticus, a typical spike–and–wave complex
appears at 3 Hz rate (154). In Creutzfeld–Jacob disease, herpes simplex encephalitis, and
hepatic encephalopathy, the EEG shows periodic discharges of various frequencies (155-157).
Most of the numerous case reports and correspondence communications on
sevoflurane–induced epileptiform EEG or convulsions have in common the high sevoflurane
concentration during the adverse effect (44, 50-56). The spike–generating EEG effect of high
sevoflurane concentration was compared with isoflurane in a study of a population of patients
with refractory epilepsy. This property was more prominent with sevoflurane than with
isoflurane, but in this special patient group, also high–dose isoflurane increased spike
frequency compared with that of awake recordings (158).
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JERKING MOVEMENTS DURING SEVOFLURANE INDUCTION
Jerking movements were observed during the early phase of 8% sevoflurane induction
in eight out of 90 adult patients and in none of the children. These movements were twitching
of the arms and shoulders in six patients, twitching of all extremities in one patient, and
plantar flexion in one. These movements lasted approximately 30 seconds and subsided
spontaneously. Slow delta with or without spikes was seen in the EEG during these
movements and PS, PSR, or PED was seen later in the EEG in these patients. The EEG
montage used in the original studies included in this thesis did not contain channels recording
directly over the motor cortex, which may in part explain the absence of spikes during
movements in some of the patients.
Myoclonus can be divided into those types which are fragments of epilepsy and those
which are nonepileptic. Epileptic myoclonus is viewed as the effect of an isolated spike on
neurons of the motor system (159). Nonepileptic myoclonus may represent a dyskinetic
disturbance caused by the breakdown of the motor control systems of the cerebellum (160).
Prominent spiking as in our patients is also seen in connection with myoclonic movements
due to hypoclycemia, acute cerebral anoxia, and toxic–metabolic states (160). Myoclonus is
associated with massive spike discharges and bursts of bilateral or generalized synchronous
polyspikes in patients with primary generalized epilepsy (160).
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SUMMARY
While studying the effects of sevoflurane anesthesia on hemodynamics, using the
bispectral index (BIS) as a determinant of anesthetic adequacy in day–case anesthesia,
unanticipated hyperdynamic circulatory episodes were noted during the induction phase. The
induction phase was further investigated in four consecutive studies using time domain
analysis of EEG and hemodynamic variables. Altogether, 159 subjects, of whom 127 were
adult females, and 32 were children aged 2–12 years, were included.
In the first study, the sevoflurane requirement was evaluated by use of BIS and
hemodynamic responses during laparoscopic tubal ligation (LTL). In the following studies,
time domain visual EEG analysis, non–invasive arterial pressure monitoring, and heart rate
from electrocardiography were used to investigate the effects of sevoflurane on EEG and
hemodynamics during induction of anesthesia. A classification of EEG patterns was
developed for adults and children.
BIS is an EEG–derived empiric measure of cortical hypnosis. Minimal alveolar
concentration (MAC) is a measure of spinal unresponsiveness during anesthesia. When a BIS
level of 65 served as a predetermined optimal level of cortical hypnosis during LTL, the ED95
of sevoflurane in 66% N2O and O2 was approximately 1 MAC. This provided anesthesia with
satisfactory hemodynamics and no evidence of awareness.
During induction with 8% sevoflurane in N2O and O2, a hyperdynamic circulatory
response in adults occurred during controlled hyperventilation but not when the patients were
allowed to breathe spontaneously, or when they were hyperventilated with N2O and O2 during
propofol induction.
Epileptiform EEG was frequently present in adults during 8% sevoflurane induction
with controlled hyperventilation, and to a lesser extent, during induction with spontaneous
breathing. Hyperdynamic responses coincided with interictal epileptiform EEG, which
occurred mostly during controlled hyperventilation.
Factors generating epileptiform EEG were a rapid rise in sevoflurane CNS
concentration and patient hyperventilation. The highest increases in heart rates in adults were
associated with periodic epileptiform discharges (PED) and rhythmic polyspikes (PSR).
In children, interictal epileptiform EEG (PED, PSR, and suppression with spikes, SSP)
was present during sevoflurane induction in 88% with controlled ventilation and in 20%
having spontaneous breathing. Apnea occurred in 93% of the children during induction with
spontaneous breathing.
EEG features during similar sevoflurane inductions differed between adults and
children, some patterns appearing only in adults and some only in children. Amplitudes were
higher in children; the order of the appearance of delta differed between adults and children.
Suppression was common in children but was not observed in adults.
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CONCLUSIONS
The following conclusions can be drawn from the studies:
1. 1 MAC sevoflurane in 66% N2O in O2 was sufficient to keep BIS values below 65 and
to prevent explicit memory and provide satisfactory hemodynamics during
laparoscopic tubal ligation in 95% of the patients.
2. Controlled hyperventilation during 8% sevoflurane induction in N2O and O2 provoked
hyperdynamic circulatory responses in adults. Spontaneous breathing during similar
sevoflurane induction maintained heart rates at the baseline level but decreased blood
pressures.
3. Anesthesia induction with 8% sevoflurane in N2O and O2 elicited epileptiform EEG
patterns in adults both during controlled hyperventilation and during spontaneous
breathing. The incidence of epileptiform EEG was significantly higher with controlled
hyperventilation, and rhythmic polyspikes (PSR) and periodic epileptiform discharges
(PED) coincided with hyperdynamic circulatory responses in adults.
4. Delaying the onset of hyperventilation by two minutes decreased the incidence of PED
by 50% (P = 0.07).
5. During sevoflurane induction in children, the incidence of interictal epileptiform EEG
(PSR, PED, and suppression with spikes, SSP) was higher with controlled ventilation
than with spontaneous breathing (88% and 20%, respectively). In the ventilated
children, heart rate was significantly higher at two minutes.
6. The EEG events during similar sevoflurane induction differed between adults and
children in the order of the development of delta patterns. The incidence of EEG
suppression was over 50% in children, whereas none of the adult patients developed
suppression. EEG amplitudes were higher in children.
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